Institutional investors purchased a net $4.5 million shares of MNKD during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 26.06% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 81.7 Thousand shares of Mannkind Corp